1. Maksimovic V, Pavlovic-Popovic Z, Vukmirovic S, Cvejic J, Mooranian A, Al-Salami H, Mikov M, Golocorbin-Kon S (2020) Molecular mechanism of action and pharmacokinetic properties of methotrexate. Mol Biol Rep 47(6):4699–4708
2. Di Martino V, Verhoeven DW, Verhoeven F, Aubin F, Avouac J, Vuitton L, Liote F, Thevenot T, Wendling D (2023) Busting the myth of methotrexate chronic hepatotoxicity. Nat Rev Rheumatol 19(2):96–110
3. Hamed KM, Dighriri IM, Baomar AF, Alharthy BT, Alenazi FE, Alali GH, Alenazy RH, Alhumaidi NT, Alhulayfi DH, Alotaibi YB, Alhumaidan SS, Alhaddad ZA, Humadi AA, Alzahrani SA, Alobaid RH (2022) Overview of methotrexate toxicity: a comprehensive literature review. Cureus 14(9):e29518
4. Khawaja G, El-Orfali Y (2024) Silibinin’s effects against methotrexate-induced hepatotoxicity in adjuvant-induced arthritis rat model. Pharmaceuticals (Basel) 17(4):431
5. Kayali A, Bora ES, Acar H, Yilmaz G, Erbas O (2024) Fisetin ameliorates methotrexate induced liver fibrosis. Eur Rev Med Pharmacol Sci 28(8):3112–3119